Abstract
OBJECTIVE: Apolipoprotein (apo) A-IV is an antiatherogenic apolipoprotein, which may be involved in the regulation of food intake. Plasma apoA-IV is elevated in human obesity and apoA-IV polymorphisms have been associated with the extent of obesity. Our aim was to determine the effects of weight loss on plasma apo-IV in obese adolescents and to examine the relation of apoA-IV with the degree of obesity.
DESIGN: Longitudinal intervention study of a low fat hypocaloric diet conducted in a dietary camp.
SUBJECTS: Two groups of obese adolescents (n=47 and n=29), age: 12.7±1.7 and 11.7±2.6 y, relative body mass index (RBMI): 168±24 and 175±34%, respectively.
MEASUREMENTS: Plasma total apoA-IV, apoA-I, apoB, plasma distribution of apoA-IV, leptin, lipids, and lipoproteins before and after 3 weeks of weight reduction.
RESULTS: Plasma apoA-IV decreased from 11.5±4.1 mg/dl before to 6.7±2.2 mg/dl after weight reduction in the first group (P<0.001) and to a similar extent in the second group. The relative amount of lipid-free apoA-IV and apoA-IV associated with apoA-I increased slightly, whereas apoA-IV associated with lipoproteins devoid of apoA-I decreased. ApoA-IV levels before and after weight reduction and the changes in plasma apoA-IV did not independently correlate with RBMI, weight loss, or plasma leptin.
CONCLUSION: Plasma apoA-IV decreases markedly in overweight adolescents undergoing short-term weight reduction. The decrease is not directly related to the degree of weight loss and the mechanisms underlying this reduction remain to be clarified.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Utermann G, Beisiegel U . Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification. Eur J Biochem 1979; 99: 333–343.
Duverger N, Tremp G, Caillaud JM, Emmanuel F, Castro G, Fruchart JC, Steinmetz A, Denefle P . Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science 1996; 273: 966–968.
Cohen RD, Castellani LW, Qiao JH, Van Lenten BJ, Lusis AJ, Reue K . Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J Clin Invest 1997; 99: 1906–1916.
Kronenberg F, Stuhlinger M, Trenkwalder E, Geethanjali FS, Pachinger O, von Eckardstein A, Dieplinger H . Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease. J Am Coll Cardiol 2000; 36: 751–757.
Warner MM, Guo J, Zhao Y . The relationship between plasma apolipoprotein A-IV levels and coronary heart disease. Chin Med J 2001; 114: 275–279.
Kronenberg F, Kuen E, Ritz E, Junker R, König P, Kraatz G, Lhotta K, Mann JFE, Müller GA, Neyer U, Riegel W, Riegler P, Schwenger V, von Eckardstein A . Apolipoprotein A-IV serum concentrations are elevated in mild and moderate renal failure. J Am Soc Nephrol 2002; 13: 461–469.
Steinmetz A, Barbaras R, Ghalim N, Clavey V, Fruchart JC, Ailhaud G . Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem 1990; 265: 7859–7863.
Ostos MA, Conconi M, Vergnes L, Baroukh N, Ribalta J, Girona J, Caillaud JM, Ochoa A, Zakin MM . Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2001; 21: 1023–1028.
Green PH, Glickman RM, Riley JW, Quinet E . Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest 1980; 65: 911–919.
Lu S, Yao Y, Meng S, Cheng X, Black DD . Overexpression of apolipoprotein A-IV enhances lipid transport in newborn swine intestinal epithelial cells. J Biol Chem 2002; 277: 31929–31937.
Tso P, Liu M, Kalogeris TJ, Thomson AB . The role of apolipoprotein A-IV in the regulation of food intake. Annu Rev Nutr 2001; 21: 231–254.
Lefevre M, Lovejoy JC, DeFelice SM, Keener JW, Bray GA, Ryan DH, Hwang DH, Greenway FL . Common apolipoprotein A-IV variants are associated with differences in body mass index levels and percentage body fat. Int J Obes Relat Metab Disord 2000; 24: 945–953.
Heilbronn LK, Noakes M, Morris AM, Kind KL, Clifton PM . 360His polymorphism of the apolipoprotein A-IV gene and plasma lipid response to energy restricted diets in overweight subjects. Atherosclerosis 2000; 150: 187–192.
Fiegenbaum M, Hutz MH . Further evidence for the association between obesity-related traits and the apolipoprotein A-IV gene. Int J Obes Relat Metab Disord 2003; 27: 484–490.
Strobl W, Knerer B, Gratzl R, Arbeiter K, Lin-Lee YC, Patsch W . Altered regulation of apolipoprotein A-IV gene expression in the liver of the genetically obese Zucker rat. J Clin Invest 1993; 92: 1766–1773.
Ferrante Jr AW, Thearle M, Liao T, Leibel RL . Effects of leptin deficiency and short-term repletion on hepatic gene expression in genetically obese mice. Diabetes 2001; 50: 2268–2278.
Verges B, Guerci B, Durlach V, Galland-Jos C, Paul JL, Lagrost L, Gambert P . Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects. J Lipid Res 2001; 42: 2021–2029.
Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiß HC, Hesse V, von Hippel A, Jaeger U, Johnsen D, Korte W, Menner K, Müller G, Müller JM, Niemann-Pilatus A, Remer T, Schaefer F, Wittchen HU, Zabransky S, Zellner K, Ziegler A, Hebebrand J . Perzentile für den Body-mass-Index für das Kindes-und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001; 149: 807–818.
Kronenberg F, Lobentanz EM, Konig P, Utermann G, Dieplinger H . Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. J Lipid Res 1994; 35: 1318–1328.
Ezeh B, Haiman M, Alber HF, Kunz B, Paulweber B, Lingenhel A, Kraft HG, Weidinger F, Pachinger O, Dieplinger H, Kronenberg F . Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls. J Lipid Res 2003; 44: 1523–1529.
Sherman JR, Weinberg RB . Serum apolipoprotein A-IV and lipoprotein cholesterol in patients undergoing total parenteral nutrition. Gastroenterology 1988; 95: 394–401.
Zimmerman J, Kaufmann NA, Fainaru M, Eisenberg S, Oschry Y, Friedlander Y, Stein Y . Effect of weight loss in moderate obesity on plasma lipoprotein and apolipoprotein levels and on high density lipoprotein composition. Arteriosclerosis 1984; 4: 115–123.
Sun Z, Larson IA, Ordovas JM, Barnard JR, Schaefer EJ . Effects of age, gender, and lifestyle factors on plasma apolipoprotein A-IV concentrations. Atherosclerosis 2000; 151: 381–388.
Sun Z, Welty FK, Dolnikowski GG, Lichtenstein AH, Schaefer EJ . Effects of a National Cholesterol Education Program Step II Diet on apolipoprotein A-IV metabolism within triacylglycerol-rich lipoproteins and plasma. Am J Clin Nutr 2001; 74: 308–314.
Weinberg RB, Dantzker C, Patton CS . Sensitivity of serum apolipoprotein A-IV levels to changes in dietary fat content. Gastroenterology 1990; 98: 17–24.
Koenig J, Elmadfa I . Food-based dietary guidelines—the Austrian perspective. Br J Nutr Suppl 1999; 81: S31–S35.
Ehnholm C, Tenkanen H, Deknijff P, Havekes L, Rosseneu M, Menzel HJ, Tiret L . Genetic polymorphism of apolipoprotein A-IV in five different regions of Europe. Relations to plasma lipoproteins and to history of myocardial infarction: The EARS study. Atherosclerosis 1994; 107: 229–238.
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF . Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292–295.
Rosenbaum M, Nicolson M, Hirsch J, Murphy E, Chu F, Leibel RL . Effects of weight change on plasma leptin concentrations and energy expenditure. J Clin Endocrinol Metab 1997; 82: 3647–3654.
Dubuc GR, Phinney SD, Stern JS, Havel PJ . Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metabolism 1998; 47: 429–434.
Morton NM, Emilsson V, Liu YL, Cawthorne MA . Leptin action in intestinal cells. J Biol Chem 1998; 273: 26194–26201.
Hassink SG, Sheslow DV, de Lancey E, Opentanova I, Considine RV, Caro JF . Serum leptin in children with obesity: relationship to gender and development. Pediatrics 1996; 98: 201–213.
Lagrost L, Gambert P, Meunier S, Morgado P, Desgres J, d'Athis P, Lallemant C . Correlation between apolipoprotein A-IV and triglyceride concentrations in human sera. J Lipid Res 1989; 30: 701–710.
Schwarz S, Haas B, Luley C, Schafer JR, Steinmetz A . Quantification of apolipoprotein A-IV in human plasma by immunonephelometry. Clin Chem 1994; 40: 1717–1721.
Acknowledgements
This study was supported by the Jubliäumsfonds der Österreichischen Nationalbank (Project #8830 to W Strobl and Project #9331 to F Kronenberg) and in part by the Austrian Science Fund (Project #13649 BIO to W Strobl).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lingenhel, A., Eder, C., Zwiauer, K. et al. Decrease of plasma apolipoprotein A-IV during weight reduction in obese adolescents on a low fat diet. Int J Obes 28, 1509–1513 (2004). https://doi.org/10.1038/sj.ijo.0802789
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0802789
Keywords
This article is cited by
-
Evaluating the Causal Relation of ApoA-IV with Disease-Related Traits - A Bidirectional Two-sample Mendelian Randomization Study
Scientific Reports (2017)
-
Minor allele of the APOA4 gene T347S polymorphism predisposes to obesity in postmenopausal Turkish women
Molecular Biology Reports (2012)
-
Decrease of Lp(a) during weight reduction in obese children is modified by the apo(a) kringle-IV copy number variation
International Journal of Obesity (2009)
-
Apolipoprotein A‐IV, a Putative Satiety/Antiatherogenic Factor, Rises After Gastric Bypass
Obesity (2009)
-
Ghrelin and Apolipoprotein AIV Levels Show Opposite Trends to Leptin Levels During Weight Loss in Morbidly Obese Patients
Obesity Surgery (2009)